Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coca-Cola effect on erlotinib absorption
NL-OMON24483Phase 4Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of erlotinib in bronchial carcinoma (2 arms), sponsored by Erasmus MC. Started Mar 2014; status: active, not recruiting.
02
Drugs
erlotinib
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on NL-OMON24483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24483.